| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |